NCT00669071 - Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Melasma

Interventions

DRUG

Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%

Applied once daily at bedtime on one side of the face; this was a randomized, split face study where one cream was used on the right side of the face and the other cream on the left side of the face and IPL (Intense Pulsed Light) was used on both sides of the face.

DRUG

Cetaphil® Moisturizing Cream as Inactive Control

Applied once daily at bedtime on the opposite side of the face; this was a randomized, split face study where one cream was used on the right side of the face and the other cream on the left side of the face and IPL (Intense Pulsed Light) was used on both sides of the face.

Trial Locations (2)

37215

Tennessee Clinical Research Center, Nashville

92037

Dermatology/Cosmetic Laser Associates of La Jolla, Inc., La Jolla